High incidence of the CD8/9 (+G) beta 0-thalassemia mutation in Spain

• Published in: Haematologica (Roma) Vol. 83; no. 12; pp. 1066 - 1068
• Main Authors: Villegas, A, Ropero, P, Ataulfo Gonzalez, F, Marti, E, Anguita, E, de Blas, JM
• Format: Journal Article
• Language: English
• Published: Italy 01-12-1998
• Subjects: beta-Thalassemia - genetics; CD8 Antigens - genetics; Female; Frameshift Mutation; Heterozygote; Homozygote; Humans; Male; Spain
• ISSN: 0390-6078; 1592-8721

Departamento de Hematologia y Hemoterapia, Hospital Universitario San Carlos, Madrid, Spain.
BACKGROUND AND OBJECTIVE: In Spain, as in other Mediterranean regions the most common beta-thalassemia mutations are due to point mutations in gene regions that are critical for production of mRNA, such as [IVS-I-nt1 (G-->A), IVS-I-nt6 (T-->C), IVS-I-nt110 (G-->A)] which interrupt normal RNA processing or nonsense mutations [CD39 (C-->T)] which interrupt the translation of mRNA. The frameshift mutation CD8/9 (+G) is a very common allele in Asian Indians but is rare in the Mediterranean regions in which isolated alleles with this mutation have been found in Israel, Greece, Portugal and Turkey. DESIGN AND METHODS: We performed a molecular analysis of 175 chromosomes corresponding to 233 beta-thalassemia patients (221 heterozygous, 10 homozygous and 2 compound heterozygous) who belong to 169 Spanish families. The study of beta-thalassemia was made by PCR-ARMS, the alpha genes by Southern blot, the phenotype of Hb Lepore by enzymatic amplification and the presence of -158 gamma G C-->T mutation by PCR and digestion with the restriction enzyme XmnL. RESULTS: Twenty of these 233 patients showed the beta-thalassemia mutation CD8/9 (+G) (17 were heterozygous, 2 homozygous and in one patient the mutation was associated with a structural variant Hb Lepore Boston). INTERPRETATION AND CONCLUSIONS: These data reveal the heterogeneity of beta-thalassemia in Spain and the relatively high frequency (8.6%) of the frameshift mutation CD8/9 (+G). It is surprising that homozygotes for beta zero-thalassemia due to this mutation with very high Hb F values (around 90%) present a phenotype of intermediate thalassemia.